PSNLPersonalis, Inc.


$ 5.85 $ -0.15 (-2.5 %)    

Thursday, 12-Sep-2024 10:09:02 EDT
QQQ $ 468.72 $ 0.09 (0.02 %)
DIA $ 408.12 $ -1.34 (-0.33 %)
SPY $ 554.24 $ -0.75 (-0.14 %)
TLT $ 100.21 $ -0.16 (-0.16 %)
GLD $ 235.27 $ 0.63 (0.27 %)
$ na
$ 6.00
$ 5.83 x 200
$ 5.87 x 100
$ 6.00 - $ 6.00
$ 0.89 - $ 7.20
1,857,538
na
315.79M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-maintains-buy-on-personalis-raises-price-target-to-9

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price ta...

 btig-maintains-buy-on-personalis-raises-price-target-to-7

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $5.5 to $7.

 needham-maintains-buy-on-personalis-raises-price-target-to-725

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $5.5 to $7.25.

Core News & Articles

Tempus invests $36 million by exercising warrants and purchasing additional sharesPersonalis, Inc. (NASDAQ:PSNL) and Tempus AI,...

 personalis-q2-2024-gaap-eps-024-beats-038-estimate-sales-22580m-beat-19262m-estimate

Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.38) by...

Core News & Articles

- SEC Filing

 needham-reiterates-buy-on-personalis-maintains-35-price-target

Needham analyst Mike Matson reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $3.5 price target.

 personalis-to-present-next-personal-ultra-sensitive-mrd-performance-in-early-stage-breast-cancer-recurrence-detection-and-immunotherapy-monitoring-at-asco-2024

Personalis will host a webinar call on June 19th, 2024 at 1:00 p.m. Pacific Time / 4:00 p.m. Eastern Time to present ASCO highl...

 needham-reiterates-buy-on-personalis-maintains-35-price-target

Needham analyst Mike Matson reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $3.5 price target.

 personalis-q1-2024-gaap-eps-026-beats-038-estimate-sales-19525m-beat-18358m-estimate

Personalis (NASDAQ:PSNL) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.38) by...

 lake-street-initiates-coverage-on-personalis-with-buy-rating-announces-price-target-of-4

Lake Street analyst Thomas Flaten initiates coverage on Personalis (NASDAQ:PSNL) with a Buy rating and announces Price Targe...

 cathie-woods-ark-laps-up-33m-worth-of-tesla-as-stock-falls-for-3rd-straight-session-sheds-shares-of-this-sports-betting-company

Tesla found favor with bullish fund manager Cathie Wood, as her firm lapped up Tesla shares following its 10% slide over three ...

 needham-reiterates-buy-on-personalis-maintains-35-price-target

Needham analyst Mike Matson reiterates Personalis (NASDAQ:PSNL) with a Buy and maintains $3.5 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION